Argenx
ARGX
£401.25
Share price
-1.42%
Change (1 day)
34.52%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Market capitalization of Argenx (ARGX)
Market cap: £25.91 Billion
As of June 2025 Argenx has a market cap of £25.91 Billion. This makes Argenx the world's 611th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Argenx from 2014 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | £25.91 B | -13.18% |
| 2024 | £29.84 B | 68.48% |
| 2023 | £17.71 B | 2.25% |
| 2022 | £17.32 B | 27.16% |
| 2021 | £13.62 B | 32.44% |
| 2020 | £10.28 B | 96.11% |
| 2019 | £5.24 B | 89.91% |
| 2018 | £2.76 B | 86.2% |
| 2017 | £1.48 B | |
| 2014 | £93.47 M |
End of Day market cap according to different sources
On Jun 16th, 2025 the market cap of Argenx was reported to be:
£24.82 Billion
£25.03 Billion